Chapman Rowan E
SEC CIK 1786240 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NTRA | Natera, Inc. | Dir | 4,663 | — | $5.13M | 30 | 2021-07-19 | 2026-07-15 |
Most active insiders at NTRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Rabinowitz Matthew | EXECUTIVE COB, Dir | — | $124.05M |
| 2 | Chapman Steven Leonard | CEO AND Pres, Dir | — | $93.95M |
| 3 | BOTHA ROELOF | Dir | — | $34.89M |
| 4 | RABINOWITZ DANIEL | SEC. AND CLO | — | $23.83M |
| 5 | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | — | $22.88M |
| 6 | Sheena Jonathan | Dir, CO-FOUNDER | — | $22.83M |
| 7 | Brophy Michael Burkes | CFO | — | $22.14M |
| 8 | ROSENMAN HERM | Dir | — | $15.14M |
| 9 | Fesko John | Pres, CHIEF BUS. Off | — | $9.35M |
| 10 | Baynes Roy D. | Dir | — | $2.81M |
| 12 | Chapman Rowan E | Dir | — | $1.76M |
Transactions 30
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-07-17 21:05 | 2026-07-15 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale | $274.82 | -135 | 4,663 | -3% | -$37.1K |
| M | 2026-06-30 20:05 | 2026-06-26 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | A - Grant | — | +1,674 | 4,798 | +54% | — |
| T | 2026-06-17 21:05 | 2026-06-16 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale | $216.78 | -2,964 | 3,124 | -49% | -$642.5K |
| M | 2026-04-28 20:35 | 2026-04-24 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | A - Grant | — | +336 | 6,088 | +6% | — |
| 2026-03-17 | 2026-03-13 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale | $191.38 | -122 | 5,752 | -2% | -$23.3K | |
| 2026-02-03 | 2026-01-30 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | A - Grant | — | +97 | 5,874 | +2% | — | |
| DM | 2025-12-09 | 2025-12-05 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale+OE | $243.11 | -4,366 | 5,777 | -43% | -$1.06M |
| D | 2025-12-09 | 2025-12-05 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | M - OptEx | $32.15 | +4,000 | 10.1K | +65% | +$128.6K |
| 2025-11-04 | 2025-10-31 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | A - Grant | — | +128 | 6,143 | +2% | — | |
| M | 2025-09-02 | 2025-06-27+ | NTRA | Natera, Inc. | Chapman Rowan E | Dir | A - Grant | — | +2,563 | 8,765 | +41% | — |
| 2025-09-02 | 2025-08-28 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale | $166.99 | -2,750 | 6,015 | -31% | -$459.2K | |
| 2024-12-11 | 2024-12-10 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale | $170.24 | -1,767 | 6,202 | -22% | -$300.8K | |
| D | 2024-09-16 | 2024-09-13 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | M - OptEx | $94.14 | +2,614 | 10.6K | +33% | +$246.1K |
| D | 2024-09-16 | 2024-09-13 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale+OE | $127.68 | -2,614 | 7,969 | -25% | -$333.8K |
| 2024-07-02 | 2024-06-28 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | A - Grant | — | +2,964 | 7,969 | +59% | — | |
| 2024-05-30 | 2024-05-28 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale | $109.09 | -4,856 | 5,005 | -49% | -$529.7K | |
| 2024-04-30 | 2024-04-26 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | A - Grant | — | +488 | 9,861 | +5% | — | |
| 2023-12-01 | 2023-11-29 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale | $55.97 | -1,998 | 9,373 | -18% | -$111.8K | |
| D | 2023-07-05 | 2023-06-30 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | A - Grant | — | +2,750 | 11.4K | +32% | — |
| 2023-06-15 | 2023-06-13 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale | $50.58 | -1,767 | 8,621 | -17% | -$89.4K | |
| D | 2023-05-26 | 2023-05-25 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | M - OptEx | — | +3,534 | 10.4K | +52% | — |
| 2022-10-18 | 2022-10-14 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | A - Grant | $45.42 | +330 | 6,854 | +5% | +$15.0K | |
| A | 2022-09-02 | 2022-07-08 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | A - Grant | $0.00 | +361 | 6,524 | +6% | $0 |
| D | 2022-05-27 | 2022-05-25 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | M - OptEx | — | +1,307 | 6,163 | +27% | — |
| DM | 2021-09-21 | 2021-09-17 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale+OE | $120.78 | -5,500 | 9,356 | -37% | -$664.3K |
| D | 2021-09-21 | 2021-09-17 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | M - OptEx | $32.15 | +5,500 | 10.4K | +113% | +$176.8K |
| D | 2021-08-19 | 2021-08-17 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale+OE | $100.09 | -5,500 | 4,856 | -53% | -$550.5K |
| D | 2021-08-19 | 2021-08-17 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | M - OptEx | $32.15 | +5,500 | 10.4K | +113% | +$176.8K |
| D | 2021-07-21 | 2021-07-19 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | M - OptEx | $40.93 | +3,000 | 7,856 | +62% | +$122.8K |
| DM | 2021-07-21 | 2021-07-19 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale+OE | $108.32 | -3,000 | 4,856 | -38% | -$325.0K |
Purchase Sale Sale after option exercise All abbreviations